These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Antibodies to glutamic acid decarboxylase define a form of limbic encephalitis. Malter MP, Helmstaedter C, Urbach H, Vincent A, Bien CG. Ann Neurol; 2010 Apr; 67(4):470-8. PubMed ID: 20437582 [Abstract] [Full Text] [Related]
4. Pilomotor seizures and status in non-paraneoplastic limbic encephalitis. Wieser S, Kelemen A, Barsi P, Vincent A, Borbely C, Rasonyi G, Mueller S, Hess K, Wieser HG, Halasz P. Epileptic Disord; 2005 Sep; 7(3):205-11. PubMed ID: 16162429 [Abstract] [Full Text] [Related]
5. Plasma exchange for anti GAD associated non paraneoplastic limbic encephalitis. Mazzi G, Roia DD, Cruciatti B, Matà S, Catapano R. Transfus Apher Sci; 2008 Dec; 39(3):229-33. PubMed ID: 18955013 [Abstract] [Full Text] [Related]
6. Anti-glutamic acid decarboxylase limbic encephalitis without epilepsy evolving into dementia with cerebellar ataxia. Mirabelli-Badenier M, Morana G, Pinto F, Uccelli A, Veneselli E, Battaglia FM, Biancheri R, Baglietto MG, Vincent A, Mancardi MM. Arch Neurol; 2012 Aug; 69(8):1064-6. PubMed ID: 22507885 [Abstract] [Full Text] [Related]
8. [Autoimmune epilepsy]. Seeck M, Zacharia A, Rossetti AO. Rev Med Suisse; 2010 May 05; 6(247):925-9. PubMed ID: 20499581 [Abstract] [Full Text] [Related]
9. Non-paraneoplastic limbic encephalitis associated with anti-glutamic acid decarboxylase antibodies. Matà S, Muscas GC, Naldi I, Rosati E, Paladini S, Cruciatti B, Bisulli F, Paganini M, Mazzi G, Sorbi S, Tinuper P. J Neuroimmunol; 2008 Aug 13; 199(1-2):155-9. PubMed ID: 18586329 [Abstract] [Full Text] [Related]
10. Limbic encephalitis associated with anti-GAD antibody and common variable immune deficiency. Akman CI, Patterson MC, Rubinstein A, Herzog R. Dev Med Child Neurol; 2009 Jul 13; 51(7):563-7. PubMed ID: 19191828 [Abstract] [Full Text] [Related]
11. Spectrum of neurological syndromes associated with glutamic acid decarboxylase antibodies: diagnostic clues for this association. Saiz A, Blanco Y, Sabater L, González F, Bataller L, Casamitjana R, Ramió-Torrentà L, Graus F. Brain; 2008 Oct 13; 131(Pt 10):2553-63. PubMed ID: 18687732 [Abstract] [Full Text] [Related]
12. Limbic encephalitis and type 1 diabetes with glutamic acid decarboxylase 65 (GAD65) autoimmunity: improvement with high-dose intravenous immunoglobulin therapy. Lopez-Sublet M, Bihan H, Reach G, Dupont S, Didelot A, Mourad JJ, Krivitzky A, Dhote R. Diabetes Metab; 2012 Jun 13; 38(3):273-5. PubMed ID: 22463975 [Abstract] [Full Text] [Related]
14. Glutamic acid decarboxylase antibodies in idiopathic generalized epilepsy and type 1 diabetes. Striano P, Perruolo G, Errichiello L, Formisano P, Beguinot F, Zara F, Striano S. Ann Neurol; 2008 Jan 13; 63(1):127-8. PubMed ID: 17167787 [No Abstract] [Full Text] [Related]
15. Seizure control and cognitive improvement via immunotherapy in late onset epilepsy patients with paraneoplastic versus GAD65 autoantibody-associated limbic encephalitis. Hansen N, Widman G, Witt JA, Wagner J, Becker AJ, Elger CE, Helmstaedter C. Epilepsy Behav; 2016 Dec 13; 65():18-24. PubMed ID: 27855355 [Abstract] [Full Text] [Related]
16. Antiglutamic acid decarboxylase 65 (GAD65) antibody-associated epilepsy. Daif A, Lukas RV, Issa NP, Javed A, VanHaerents S, Reder AT, Tao JX, Warnke P, Rose S, Towle VL, Wu S. Epilepsy Behav; 2018 Mar 13; 80():331-336. PubMed ID: 29433947 [Abstract] [Full Text] [Related]